Literature DB >> 22183544

The solvated interaction energy method for scoring binding affinities.

Traian Sulea1, Enrico O Purisima.   

Abstract

The solvated interaction energy (SIE) is an end-point, physics-based scoring function for predicting ligand-binding affinities. It supplements the force-field interaction energy with the desolvation cost of binding. Parameters such as the solute dielectric constant, Born radii, a cavity term and an overall scaling coefficient and additive constant have been previously calibrated against a training set of 99 protein-ligand complexes. We describe the application of the method to estimating binding free energies from molecular dynamics trajectories of protein-ligand binding complexes.

Mesh:

Substances:

Year:  2012        PMID: 22183544     DOI: 10.1007/978-1-61779-465-0_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Small-molecule inhibitors of the pseudaminic acid biosynthetic pathway: targeting motility as a key bacterial virulence factor.

Authors:  Robert Ménard; Ian C Schoenhofen; Limei Tao; Annie Aubry; Patrice Bouchard; Christopher W Reid; Paule Lachance; Susan M Twine; Kelly M Fulton; Qizhi Cui; Hervé Hogues; Enrico O Purisima; Traian Sulea; Susan M Logan
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

2.  Exhaustive docking and solvated interaction energy scoring: lessons learned from the SAMPL4 challenge.

Authors:  Hervé Hogues; Traian Sulea; Enrico O Purisima
Journal:  J Comput Aided Mol Des       Date:  2014-01-29       Impact factor: 3.686

3.  Binding pose and affinity prediction in the 2016 D3R Grand Challenge 2 using the Wilma-SIE method.

Authors:  Hervé Hogues; Traian Sulea; Francis Gaudreault; Christopher R Corbeil; Enrico O Purisima
Journal:  J Comput Aided Mol Des       Date:  2017-10-05       Impact factor: 3.686

4.  A Rational Engineering Strategy for Designing Protein A-Binding Camelid Single-Domain Antibodies.

Authors:  Kevin A Henry; Traian Sulea; Henk van Faassen; Greg Hussack; Enrico O Purisima; C Roger MacKenzie; Mehdi Arbabi-Ghahroudi
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

5.  Assisted Design of Antibody and Protein Therapeutics (ADAPT).

Authors:  Victor Vivcharuk; Jason Baardsnes; Christophe Deprez; Traian Sulea; Maria Jaramillo; Christopher R Corbeil; Alaka Mullick; Joanne Magoon; Anne Marcil; Yves Durocher; Maureen D O'Connor-McCourt; Enrico O Purisima
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

6.  Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironment.

Authors:  Traian Sulea; Nazanin Rohani; Jason Baardsnes; Christopher R Corbeil; Christophe Deprez; Yuneivy Cepero-Donates; Alma Robert; Joseph D Schrag; Marie Parat; Mélanie Duchesne; Maria L Jaramillo; Enrico O Purisima; John C Zwaagstra
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

7.  Structure-based dual affinity optimization of a SARS-CoV-1/2 cross-reactive single-domain antibody.

Authors:  Traian Sulea; Jason Baardsnes; Matthew Stuible; Nazanin Rohani; Anh Tran; Marie Parat; Yuneivy Cepero Donates; Mélanie Duchesne; Pierre Plante; Guneet Kour; Yves Durocher
Journal:  PLoS One       Date:  2022-03-30       Impact factor: 3.752

8.  Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) improves efficacy of a Clostridium difficile toxin A single-domain antibody.

Authors:  Traian Sulea; Greg Hussack; Shannon Ryan; Jamshid Tanha; Enrico O Purisima
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

9.  Binding and functional profiling of antibody mutants guides selection of optimal candidates as antibody drug conjugates.

Authors:  John C Zwaagstra; Traian Sulea; Jason Baardsnes; Stevo Radinovic; Yuneivy Cepero-Donates; Alma Robert; Maureen D O'Connor-McCourt; Ilia A Tikhomirov; Maria Luz Jaramillo
Journal:  PLoS One       Date:  2019-12-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.